1. [1] Bakker K, Apelqvist J, Schaper NC, Board IWGotDFE. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 2012; 28: 225-231. https://doi.org/10.1002/dmrr.2254 [DOI:10.1002/dmrr.2253]

2. [2] Boulton AJ, Kirsner RS, Vileikyte L. Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med 2004; 351: 48-55. [DOI:10.1056/NEJMcp032966] [PMID]

3. [3] Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50: 18-25. [DOI:10.1007/s00125-006-0491-1] [PMID]

4. [4] Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Annal Med 2017; 49: 106-116. [DOI:10.1080/07853890.2016.1231932] [PMID]

5. [5] Tabatabaei-Malazy O, Mohajeri-Tehrani MR, Pajouhi M, Fard AS, Amini MR, Larijani B. Iranian diabetic foot research network. Adv Skin Wound Care 2010; 23: 450-454. [DOI:10.1097/01.ASW.0000383222.79771.93] [PMID]

6. [6] Yazdanpanah L, Shahbazian H, Nazari I, Arti HR, Ahmadi F, Mohammadianinejad SE, et al. Prevalence and related risk factors of diabetic foot ulcer in Ahvaz, south west of Iran. Diabetes Metab Syndr 2018; 12: 519-524. [DOI:10.1016/j.dsx.2018.03.018] [PMID]

7. [7] Bus SA, Waaijman R, Arts M, De Haart M, Busch-Westbroek T, Van Baal J, et al. Effect of custom-made footwear on foot ulcer recurrence in diabetes: a multicenter randomized controlled trial. Diabetes Care 2013; 36: 4109-4116. [DOI:10.2337/dc13-0996] [PMID] [PMCID]

8. [8] Pound N, Chipchase S, Treece K, Game F, Jeffcoate W. Ulcer‐free survival following management of foot ulcers in diabetes. Diabet Med 2005; 22: 1306-1309. [DOI:10.1111/j.1464-5491.2005.01640.x] [PMID]

9. [9] Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 2000; 23: 606-611. [DOI:10.2337/diacare.23.5.606] [PMID]

10. [10] Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 1998; 21: 1714-1719. [DOI:10.2337/diacare.21.10.1714] [PMID]

11. [11] Monteiro‐Soares M, Boyko E, Ribeiro J, Ribeiro I, Dinis‐Ribeiro M. Predictive factors for diabetic foot ulceration: a systematic review. Diabet Metab Res Rev 2012; 28: 574-600. [DOI:10.1002/dmrr.2319] [PMID]

12. [12] Ahroni JH, Boyko EJ, Forsberg RC. Clinical correlates of plantar pressure among diabetic veterans. Diabetes Care 1999; 22: 965-972. [DOI:10.2337/diacare.22.6.965] [PMID]

13. [13] Soltany S, Alavy Toussy J, Malek M, Hemmaty H-R, Maghsoomi Z. Effects of oral pentoxyphylline on the healing of foot ulcers in the diabetic patients. Koomesh 2014; 16: 8-13. (Persian).

14. [14] Abbott C, Carrington A, Ashe H, Bath S, Every L, Griffiths J, et al. The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort. Diabet Med 2002; 19: 377-384. [DOI:10.1046/j.1464-5491.2002.00698.x] [PMID]

15. [15] Bus S, Van Deursen R, Armstrong D, Lewis JE, Caravaggi C, Cavanagh P, et al. Footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic review. Diabet Metab Res Rev 2016; 32: 99-118. https://doi.org/10.1002/dmrr.2697 [DOI:10.1002/dmrr.2702] [PMID]

16. [16] Bus SA, Valk G, Van Deursen R, Armstrong D, Caravaggi C, Hlaváček P, et al. The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabet Metab Res Rev 2008; 24: S162-S180. [DOI:10.1002/dmrr.850] [PMID]

17. [17] Dizon JM, Machingaidze S, Grimmer K. To adopt, to adapt, or to contextualise? The big question in clinical practice guideline development. BMC Res Notes 2016; 9: 442. [DOI:10.1186/s13104-016-2244-7] [PMID] [PMCID]

18. [18] van Bruggen R, Gorter KJ, Stolk RP, Verhoeven RP, Rutten GE. Implementation of locally adapted guidelines on type 2 diabetes. Fam Pract 2008; 25: 430-437. [DOI:10.1093/fampra/cmn045] [PMID]

19. [19] Alaei M. The new EASL guidelines for the management of chronic hepatitis B infection adapted for Swiss physicians. Swiss Med Wkly 2010; 140: 154-159.

20. [20] Mollarahimi F NM, Biglari M, Azvaji Kh. Adaptation of preventive guideline of cardiovascular disease. Razi J Med Sci 2017; 23: 46-53. (Persian).

21. [21] Sadeghi A, Navabakhsh B, Shafiee G, Aalaa M, Larijani MB, Firooz A, et al. Hirsutism: A clinical practice guideline of diagnosis and treatment in Iran. J Dermatol Cosmetic 2013; 4: 167-187. (Persian).

22. [22] Rajavi Z, Javadi MA, Daftarian N, Safi S, Nejat F, Shirvani A, et al. Customized clinical practice guidelines for management of adult cataract in Iran. J Ophthalmic Vis Res 2015; 10: 445-460. [DOI:10.4103/2008-322X.176913] [PMID] [PMCID]

23. [23] Shafiee Z, GHahari M, Hosseini MA, Rezaee M, Rassafiani M. Localization of occupational therapy clinical practice guideline to improve the upper extremity function in patients with stroke: an integrative review and expert panel. 2015. (Persian).

24. [24] Collaboration A. Guideline adaptation: a resource toolkit (Version 2.0). Perthshire, Scot: Guidelines International Network; 2011.

25. [25] Group GW. The grading of recommendations assessment, development and evaluation (GRADE) working group website. 2013.

26. [26] Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 2010; 182: E839-E842. [DOI:10.1503/cmaj.090449] [PMID] [PMCID]

27. [27] Agree C. Appraisal of guidelines for research & evaluation (AGREE) instrument. The AGREE Collaboration (ed). 2001.

28. [28] Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol 2014; 67: 401-409. [DOI:10.1016/j.jclinepi.2013.12.002] [PMID]

29. [29] Graham I, Harrison M, Brouwers M. Evaluating and adapting practice guidelines for local use: a conceptual framework. Clinical governance in practice London: Harcourt 2003; 213-229.

30. [30] Glasier A, Brechin S, Raine R, Penney G. A consensus process to adapt the World Health Organization selected practice recommendations for UK use. Contraception 2003; 68: 327-333. [DOI:10.1016/j.contraception.2003.07.007] [PMID]

31. [31] Naude L, Smart H, Tudhope L, Janse van Rensburg G, Alexander H, Abdool-Carrim T, et al. WHASA consensus document on the management of the diabetic foot. Wound Healing Southern Afric 2015; 8: 17-30.

32. [32] Naude L, Smart H, Tudhope L, van Rensburg GJ, Alexander H, Abdool-Carrim T, et al. WHASA consensus document on the management of the diabetic foot: consensus document. South Afric Fam Pract 2015; 57: 39-51.

33. [33] Bakker K, Apelqvist J, Lipsky B, Van Netten J, Schaper N, Foot IWGotD. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence‐based global consensus. Diabet Metab Res Rev 2016; 32: 2-6. [DOI:10.1002/dmrr.2694] [PMID]

34. [34] Lewis J, Lipp A. Pressure‐relieving interventions for treating diabetic foot ulcers. Cochrane Database Syst Rev 2013. [DOI:10.1002/14651858.CD002302.pub2] [PMID]

35. [35] Morona JK, Buckley ES, Jones S, Reddin EA, Merlin TL. Comparison of the clinical effectiveness of different off‐loading devices for the treatment of neuropathic foot ulcers in patients with diabetes: a systematic review and meta‐analysis. Diabet Metab Res Rev 2013; 29: 183-193. [DOI:10.1002/dmrr.2386] [PMID]

36. [36] Armstrong DG, Nguyen HC, Lavery LA, Van Schie CH, Boulton AJ, Harkless LB. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001; 24: 1019-1022. [DOI:10.2337/diacare.24.6.1019] [PMID]

37. [37] Wukich DK, Motko J. Safety of total contact casting in high-risk patients with neuropathic foot ulcers. Foot Ankle Int 2004; 25: 556-560. [DOI:10.1177/107110070402500808] [PMID]

38. [38] Nabuurs-Franssen MH, Huijberts MS, Sleegers R, Schaper NC. Casting of recurrent diabetic foot ulcers: effective and safe? Diabetes Care 2005; 28: 1493-1494. [DOI:10.2337/diacare.28.6.1493] [PMID]

39. [39] Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, et al. Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study. Diabet Med 2008; 25: 700-707. [DOI:10.1111/j.1464-5491.2008.02445.x] [PMID]

40. [40] Wu SC, Jensen JL, Weber AK, Robinson DE, Armstrong DG. Use of pressure offloading devices in diabetic foot ulcers: do we practice what we preach? Diabetes Care 2008; 31: 2118-2119. [DOI:10.2337/dc08-0771] [PMID] [PMCID]

41. [41] Nabuurs-Franssen MH, Sleegers R, Huijberts MS, Wijnen W, Sanders AP, Walenkamp G, et al. Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. Diabetes Care 2005; 28: 243-247. [DOI:10.2337/diacare.28.2.243] [PMID]

42. [42] Armstrong DG, Lavery LA, Wu S, Boulton AJ. Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care 2005; 28: 551-554. [DOI:10.2337/diacare.28.3.551] [PMID]

43. [43] Faglia E, Caravaggi C, Clerici G, Sganzaroli A, Curci V, Vailati W, et al. Effectiveness of removable walker cast versus nonremovable fiberglass off-bearing cast in the healing of diabetic plantar foot ulcer: a randomized controlled trial. Diabetes Care 2010; 33: 1419-1423. [DOI:10.2337/dc09-1708] [PMID] [PMCID]

44. [44] Caravaggi C, Sganzaroli A, Fabbi M, Cavaiani P, Pogliaghi I, Ferraresi R, et al. Nonwindowed nonremovable fiberglass off-loading cast versus removable pneumatic cast (AircastXP Diabetic Walker) in the treatment of neuropathic noninfected plantar ulcers: a randomized prospective trial. Diabetes Care 2007; 30: 2577-2578. [DOI:10.2337/dc07-0990] [PMID]

45. [45] Gutekunst DJ, Hastings MK, Bohnert KL, Strube MJ, Sinacore DR. Removable cast walker boots yield greater forefoot off-loading than total contact casts. Clin Biomech 2011; 26: 649-654. [DOI:10.1016/j.clinbiomech.2011.03.010] [PMID] [PMCID]

46. [46] Armstrong DG, Lavery LA, Kimbriel HR, Nixon BP, Boulton AJ. Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care 2003; 26: 2595-2597. [DOI:10.2337/diacare.26.9.2595] [PMID]

47. [47] Dumont I, Lepeut M, Tsirtsikolou D, Popielarz S, Cordonnier M, Fayard A, et al. A proof‐of‐concept study of the effectiveness of a removable device for offloading in patients with neuropathic ulceration of the foot: the Ransart boot. Diabet Med 2009; 26: 778-782. [DOI:10.1111/j.1464-5491.2009.02772.x] [PMID]

48. [48] Dumont IJ, Tsirtsikolou D, Lepage M, Popielarz S, Fayard A, Devemy F, et al. The Ransart Boot-An offloading device for every type of Diabetic Foot Ulcer? EWMA J 2010; 10.

49. [49] Birke JA, Pavich MA, Patout Jr CA, Horswell R. Comparison of forefoot ulcer healing using alternative off-loading methods in patients with diabetes mellitus. Adv Skin Wound Care 2002; 15: 210-215. [DOI:10.1097/00129334-200209000-00006] [PMID]

50. [50] Chantelau E, Breuer U, Leisch A, Tanudjaja T, Reuter M. Outpatient treatment of unilateral diabetic foot ulcers with 'half shoes'. Diabet Med 1993; 10: 267-270. [DOI:10.1111/j.1464-5491.1993.tb00056.x] [PMID]

51. [51] Hissink RJ, Manning HA, van Baal JG. The MABAL shoe, an alternative method in contact casting for the treatment of neuropathic diabetic foot ulcers. Foot Ankle Int 2000; 21: 320-323. [DOI:10.1177/107110070002100408] [PMID]

52. [52] Rizzo L, Tedeschi A, Fallani E, Coppelli A, Vallini V, Iacopi E, et al. Custom-made orthesis and shoes in a structured follow-up program reduces the incidence of neuropathic ulcers in high-risk diabetic foot patients. Int J Low Extrem Wounds 2012; 11: 59-64. [DOI:10.1177/1534734612438729] [PMID]

53. [53] Scire V, Leporati E, Teobaldi I, Nobili LA, Rizzo L, Piaggesi A. Effectiveness and safety of using Podikon digital silicone padding in the primary prevention of neuropathic lesions in the forefoot of diabetic patients. J Am Podiatr Med Assoc 2009; 99: 28-34. [DOI:10.7547/0980028] [PMID]

54. [54] Apelqvist J, Larsson J, Agardh CD. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J Diabet Complications 1990; 4: 21-25. [DOI:10.1016/0891-6632(90)90060-I]

55. [55] Ulbrecht JS, Hurley T, Mauger DT, Cavanagh PR. Prevention of recurrent foot ulcers with plantar pressure-based in-shoe orthoses: the CareFUL prevention multicenter randomized controlled trial. Diabetes Care 2014; 37: 1982-1989. [DOI:10.2337/dc13-2956] [PMID] [PMCID]

56. [56] Waaijman R, Keukenkamp R, de Haart M, Polomski WP, Nollet F, Bus SA. Adherence to wearing prescription custom-made footwear in patients with diabetes at high risk for plantar foot ulceration. Diabetes Care 2013; 36: 1613-1618. [DOI:10.2337/dc12-1330] [PMID] [PMCID]

57. [57] Arts ML, de Haart M, Bus SA, Bakker JP, Hacking HG, Nollet F. Perceived usability and use of custom-made footwear in diabetic patients at high risk for foot ulceration. J Rehab Med 2014; 46: 357-362. [DOI:10.2340/16501977-1272] [PMID]

58. [58] Mueller MJ, Diamond JE, Sinacore DR, Delitto A, Blair VP, Drury DA, et al. Total contact casting in treatment of diabetic plantar ulcers: controlled clinical trial. Diabetes Care 1989; 12: 384-388. [DOI:10.2337/diacare.12.6.384] [PMID]

59. [59] Mueller MJ, Sinacore DR, Hastings MK, Strube MJ, Johnson JE. Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am 2003; 85: 1436-1445. [DOI:10.2106/00004623-200308000-00003] [PMID]

60. [60] Colen LB, Kim CJ, Grant WP, Yeh JT, Hind B. Achilles tendon lengthening: friend or foe in the diabetic foot? Plast Reconstr Surg 2013; 131: 37e-43e. [DOI:10.1097/PRS.0b013e3182729e0b] [PMID]

61. [61] Cunha M, Faul J, Steinberg J, Attinger C. Forefoot ulcer recurrence following partial first ray amputation: the role of tendo-achilles lengthening. J Am Podiatr Med Assoc 2010; 100: 80-82. [DOI:10.7547/1000080] [PMID]

62. [62] Holstein P, Lohmann M, Bitsch M, Jørgensen B. Achilles tendon lengthening, the panacea for plantar forefoot ulceration? Diabetes Metab Res Rev 2004; 20: S37-S40. [DOI:10.1002/dmrr.452] [PMID]

63. [63] Laborde JM. Neuropathic plantar forefoot ulcers treated with tendon lengthenings. Foot Ankle Int 2008; 29: 378-384. [DOI:10.3113/FAI.2008.0378] [PMID]

64. [64] Laborde JM. Midfoot ulcers treated with gastrocnemius-soleus recession. Foot Ankle Int 2009; 30: 842-846. [DOI:10.3113/FAI.2009.0842] [PMID]

65. [65] Armstrong DG, Fiorito JL, Leykum BJ, Mills JL. Clinical efficacy of the pan metatarsal head resection as a curative procedure in patients with diabetes mellitus and neuropathic forefoot wounds. Foot Ankle Int 2012; 5: 235-240. [DOI:10.1177/1938640012449038] [PMID]

66. [66] Armstrong DG, Rosales MA, Gashi A. Efficacy of fifth metatarsal head resection for treatment of chronic diabetic foot ulceration. J Am Podiatr Med Assoc 2005; 95: 353-356. [DOI:10.7547/0950353] [PMID]

67. [67] Molines‐Barroso R, Lázaro‐Martínez J, Aragón‐Sánchez J, García‐Morales E, Beneit‐Montesinos J, Álvaro‐Afonso F. Analysis of transfer lesions in patients who underwent surgery for diabetic foot ulcers located on the plantar aspect of the metatarsal heads. Diabet Med 2013; 30: 973-976. [DOI:10.1111/dme.12202] [PMID]

68. [68] Armstrong DG, Lavery LA, Vazquez JR, Short B, Kimbriel HR, Nixon BP, et al. Clinical efficacy of the first metatarsophalangeal joint arthroplasty as a curative procedure for hallux interphalangeal joint wounds in patients with diabetes. Diabetes Care 2003; 26: 3284-3287. [DOI:10.2337/diacare.26.12.3284] [PMID]

69. [69] Lin SS, Bono CM, Lee TH. Total contact casting and Keller arthoplasty for diabetic great toe ulceration under the interphalangeal joint. Foot Ankle Int 2000; 21: 588-593. [DOI:10.1177/107110070002100711] [PMID]

70. [70] Johnson JE, Anderson SA. One stage resection and pin stabilization of first metatarsophalangeal joint for chronic plantar ulcer with osteomyelitis. Foot Ankle Int 2010; 31: 973-979. [DOI:10.3113/FAI.2010.0973] [PMID]

71. [71] Kim J-Y, Kim TW, Park YE, Lee YJ. Modified resection arthroplasty for infected non-healing ulcers with toe deformity in diabetic patients. 2008. [DOI:10.3113/FAI.2008.0493] [PMID]

72. [72] Kearney TP, Hunt NA, Lavery LA. Safety and effectiveness of flexor tenotomies to heal toe ulcers in persons with diabetes. Diabetes Res Clin Pract 2010; 89: 224-226. [DOI:10.1016/j.diabres.2010.05.025] [PMID]

73. [73] Laborde JM. Neuropathic toe ulcers treated with toe flexor tenotomies. Foot Ankle Int 2007; 28: 1160-1164. [DOI:10.3113/FAI.2007.1160] [PMID]

74. [74] HA, Oei IH, Koning J. Functional outcome and patient satisfaction after flexor tenotomy for plantar ulcers of the toes. J Foot Ankle Surg 2010; 49: 119-122. [DOI:10.1053/j.jfas.2009.12.001] [PMID]

75. [75] Tamir E, McLaren A-M, Gadgil A, Daniels TR. Outpatient percutaneous flexor tenotomies for management of diabetic claw toe deformities with ulcers: a preliminary report. Can J Surg 2008; 51: 41.

76. [76] Tamir E, Vigler M, Avisar E, Finestone AS. Percutaneous tenotomy for the treatment of diabetic toe ulcers. Foot Ankle Int 2014; 35: 38-43. [DOI:10.1177/1071100713509604] [PMID]

77. [77] Van Netten JJ, Bril A, Van Baal JG. The effect of flexor tenotomy on healing and prevention of neuropathic diabetic foot ulcers on the distal end of the toe. J Foot Ankle Res 2013; 6: 3. [DOI:10.1186/1757-1146-6-3] [PMID] [PMCID]

78. [78] Zimny S, Schatz H, Pfohl U. The effects of applied felted foam on wound healing and healing times in the therapy of neuropathic diabetic foot ulcers. Diabet Med 2003; 20: 622-625. [DOI:10.1046/j.1464-5491.2003.01011.x] [PMID]

79. [79] Nubé VL, Molyneaux L, Bolton T, Clingan T, Palmer E, Yue DK. The use of felt deflective padding in the management of plantar hallux and forefoot ulcers in patients with diabetes. The Foot 2006; 16: 38-43. [DOI:10.1016/j.foot.2005.11.005]